Alternative to LASIK Increases Momentum with U.S. Consumers

MONROVIA, Calif., July 14 /PRNewswire-/ -- STAAR
Surgical Company (Nasdaq: STAA) announced today that
Visian ICL (Implantable Collamer Lens), a tiny, flexible
lens implanted in the eye to correct refractive errors,
continues to gain momentum with consumers in the U.S.
market. The Visian ICL is often referred to as the
"implantable contact lens" by patients and physicians.
According to preliminary data from the company, U.S.
sales of the Visian ICL grew 38% over the prior year
period. During the second quarter this accelerating rate
of Visian ICL growth contrasts sharply with an even more
significant decline in LASIK vision correction procedures.
According to a leading provider of LASIK vision
correction services, laser-based refractive procedures had
an approximate40% decline during the second quarter.
STAAR Surgical today also announced the launch of a newly
revamped and enhanced website,
http://www.visianinfo.com, designed to help consumers
more clearly understand the benefits of the Visian ICL.

source: PR Newswire